Share：
Share this content in WeChat
X
[Chinese][PDF]71680
• Editorial •
MRI in clinical diagnosis and treatment of prostate cancer
WANG Jian-ye  CHEN Xin  LIU Ming  CHEN Min 

DOI:10.3969/j.issn.1674-8034.2010.04.003.


[Abstract] Magnetic resonance imaging (MRI) is an essential part of the imaging for prostate cancer. Traditionally, MRI was mainly focus on the staging of prostate cancer. However, the application of prostate MRI became more and more extensive recently. Novel indications including prostate cancer diagnosis, prognosis for tumor differentiation, therapeutic decision and MRI-guided biopsy have been discussed by urologists. The novel functional MRI scan makes MRI more useful for prostate cancer.
[Keywords] Magnetic resonance imaging；Prostate neoplasms；Diagnosis；Treatment

WANG Jian-ye* Department of Urology, Beijing Hospital, Beijing 100730, China

CHEN Xin Department of Urology, Beijing Hospital, Beijing 100730, China

LIU Ming Department of Urology, Beijing Hospital, Beijing 100730, China

CHEN Min Department of Radiology, Beijing Hospital, Beijing 100730, China

*Correspondence to: Wang JY, E-mail: wangjianye@bjhmoh.cn

Conflicts of interest   None.

Received  2010-06-15
Accepted  2010-07-05
DOI: 10.3969/j.issn.1674-8034.2010.04.003
DOI:10.3969/j.issn.1674-8034.2010.04.003.

[1]
Franiel T, Ludemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol, 2008, 43(7): 481-487.
[2]
Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic Turbo-FLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology, 1997, 203(3): 645-652.
[3]
Seitz M, Shukla-Dave A, Bjartell A, et al. Functional magnetic resonance imaging in prostate cancer. Eur Urol, 2009, 55(4): 801-814.
[4]
Huang R, Wang XY, Wang G, et al. Analysis of mis-diagnosis of MRI in the differential diagnosis of prostate cancer. Journal of Clinical Urology, 2005, 20(6): 352-354.
[5]
Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology, 2004, 64(7):101-105.
[6]
Puech P, Huglo D, Petyt G, Lemaitre L, et al. Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Curr Opin Urol, 2009, 19(3):168-176.
[7]
Morgan VA, Kyriazi S, Ashley SE, et al. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol, 2007, 48(6):695-703.
[8]
Lawrentschuk N, Fleshner N.. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int, 2009, 103(6): 730-733.
[9]
White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology, 1995, 195(2): 385-390.
[10]
Ahmed HU, Kirkham A, Arya M, et al. Is it time to consider a role for MRI before prostate biopsy? Nature Reviews Clinical Oncology, 2009, 6(4): 197-206.
[11]
Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology, 2009, 74(5): 1094-1099.
[12]
Engelbrecht MR, Jager GJ, Laheij RJ, et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol, 2002, 12(4): 2294-2302.
[13]
de Souza NM, Riches SF, Vanas NJ, et al. Diffusion-weighted magnetic resonance imaging: a potential noninvasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol, 2008, 63(7): 774-782.
[14]
Shukla-Dave A, Hricak H, Kattan MW, et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int, 2007, 99(4): 786-793.
[15]
Kirkham AP, Emberton M, Hoh IM, et al. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology, 2008, 246(3):833-844.
[16]
Hambrock T, Futterer JJ, Huisman HJ, et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol, 2008, 43(12):686-694.
[17]
Pondman KM, Futterer JJ, ten Haken B, et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol, 2008, 54(3):517-527.
[18]
Ingh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int, 2008, 101(6):841-845.

PREV The ankle joint: MR sectional anatomy, anatomic variation and pathology: Part I-anatomy
NEXT Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopy, and the combination of three techniques
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn